No photo of Olga Frankfurt

View Scopus Profile

Olga Frankfurt

  • 1259 Citations
19992023
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Certifications and Licenses

Internal Medicine
Medical Oncology
Hematology

Training Experience

2002Residency, Rush University Medical Center
2005Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MD, University of Chicago

… → 1999

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 23 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation Medicine & Life Sciences
Hematopoietic Stem Cells Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Transplants Medicine & Life Sciences
Acute Promyelocytic Leukemia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1999 2023

Prot #INCB18424-MA-GD-301: An Open-Label, Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

Frankfurt, O.

PAREXEL International Corporation, Incyte Corporation

11/28/18 → 11/28/21

Project: Research project

Prot #BST002: A Phase 2b, Open-Label, Single Arm, Multi-Center Study to Assess the Efficacy and Safety of BST-236 as a Single Agent in Adults with Newly-Diagnosed Acute Myeloid Leukemia, Not Eligible for Standard Induction Therapy

Frankfurt, O.

PRA Health Sciences, BioSight Ltd.

10/29/18 → 10/29/21

Project: Research project

Prot #TPI-ALV-201: A Phase 2, Randomized, Biomarker-driven, Clinical Study in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with an Exploratory Arm in Patients with Newly Diagnosed High-Risk AML and Exploratory Arms with Varying Levels

Frankfurt, O.

Tolero Pharmaceuticals, Inc.

10/24/18 → 10/24/21

Project: Research project

Prot #M16-415: A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Subjects with Metastatic Castrate Resistant Prostate Cancer (CRPC) and Relapsed/Refractory Acute Myeloid Leukemia (AML)

Frankfurt, O.

AbbVie Inc.

9/27/18 → 9/27/19

Project: Research project

The Robert H. Lurie Comprehensive Cancer Center

Agulnik, M., Awatramani, R., Backman, V., Benson III, A. B., Carthew, R. W., Cella, D., Chakravarti, D., Chandel, N., Crispino, J. D., Cristofanilli, M., Eklund, E. A., Frankfurt, O., Gordon, L. I., Green, K. J., Hahn, E. A., Horbinski, C. M., Horvath, C. M., Hussain, M., James, C. D., Kelleher, N. L., Khan, S. A., LaBonne, C., Larson, A. C., Matei, D. E., Meade, T. J., Mondragon, A., Mrksich, M., Munshi, H. G., Murphy, A. B., Penedo, F. J., Perlman, H. R., Peter, M. E., Platanias, L. C., Rademaker, A. W., Rappoport, J. Z., Rosenzweig, A. C., Scheidt, K. A., Simon, M. A., Sosman, J. A., Spring, B., Wei, J., Weiss, E. L. & Woloschak, G. E.

National Cancer Institute

8/10/18 → 7/31/23

Project: Research project

Neoplasms
Medicine
Research
Population

Research Output 2004 2019

5 Citations

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

DiNardo, C. D., Pratz, K., Pullarkat, V., Jonas, B. A., Arellano, M., Becker, P. S., Frankfurt, O., Konopleva, M., Wei, A. H., Kantarjian, H. M., Xu, T., Hong, W. J., Chyla, B., Potluri, J., Pollyea, D. A. & Letai, A., Jan 3 2019, In : Blood. 133, 1, p. 7-17 11 p.

Research output: Contribution to journal › Article

decitabine
Azacitidine
Acute Myeloid Leukemia
Cytogenetics
Therapeutics

Blinatumomab and pancreatitis: an analysis of FAERS, EudraVigilance, and a large urban U.S. patient population data

Vakharia, P., Nardone, B., Budris, W., Hoshizaki, K., Frankfurt, O. & West, D. P., Jul 3 2018, In : Leukemia and Lymphoma. 59, 7, p. 1759-1761 3 p.

Research output: Contribution to journal › Editorial

Pancreatitis
Population
blinatumomab
9 Citations

Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant

Sandmaier, B. M., Khaled, S., Oran, B., Gammon, G., Trone, D. & Frankfurt, O., Feb 1 2018, In : American Journal of Hematology. 93, 2, p. 222-231 10 p.

Research output: Contribution to journal › Article

Hematopoietic Stem Cells
Acute Myeloid Leukemia
Transplants
Maximum Tolerated Dose
Recurrence
2 Citations

Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopenia

Waisbren, J., Dinner, S. N., Altman, J. K., Frankfurt, O., Helenowski, I., Gao, J., McMahon, B. J. & Stein, B. L., Jan 1 2017, In : International Journal of Hematology. 105, 1, p. 44-51 8 p.

Research output: Contribution to journal › Article

Myelodysplastic Syndromes
Thrombocytopenia
Thrombopoietin Receptors
Tertiary Care Centers
Cytogenetics
6 Citations

EBV-negative aggressive NK-cell leukemia/ lymphoma: A clinical and pathological study from a single institution

Gao, J., Behdad, A., Ji, P., Wolniak, K. L., Frankfurt, O. & Chen, Y-H., Aug 1 2017, In : Modern Pathology. 30, 8, p. 1100-1115 16 p.

Research output: Contribution to journal › Article

Large Granular Lymphocytic Leukemia
Human Herpesvirus 4
Lymphoma
Polycomb Repressive Complex 2
Natural Killer Cells